Your browser doesn't support javascript.
loading
Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study.
Chen, Qi-Yue; Zhong, Qing; Zhou, Jun-Feng; Qiu, Xian-Tu; Dang, Xue-Yi; Cai, Li-Sheng; Su, Guo-Qiang; Xu, Dong-Bo; Lin, Guang-Tan; Guo, Kai-Qing; Liu, Zhi-Yu; Chen, Qiu-Xian; Li, Ping; Li, Teng-Wen; Xie, Jian-Wei; Lin, Shuang-Ming; Wang, Jia-Bin; Lin, Jian-Xian; Lu, Jun; Cao, Long-Long; Lin, Mi; Zheng, Chao-Hui; Lin, Wei; He, Qing-Liang; Huang, Chang-Ming.
Affiliation
  • Chen QY; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Zhong Q; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Zhou JF; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Qiu XT; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Dang XY; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Cai LS; Department of Gastrointestinal Surgery and Gastrointestinal Surgery Research Institute, The Affiliated Hospital of Putian University, Putian, China.
  • Su GQ; Department of General Surgery, Shanxi Provincial Cancer Hospital, Shanxi, China.
  • Xu DB; Department of General Surgery Unit 4, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China.
  • Lin GT; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Guo KQ; Department of Gastrointestinal Surgery, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China.
  • Liu ZY; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Chen QX; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Li P; Department of General Surgery, Shanxi Provincial Cancer Hospital, Shanxi, China.
  • Li TW; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Xie JW; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Lin SM; Department of General Surgery Unit 4, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China.
  • Wang JB; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Lin JX; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Lu J; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Cao LL; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Lin M; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Zheng CH; Department of Gastrointestinal Surgery, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China.
  • Lin W; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • He QL; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
  • Huang CM; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Cancer Sci ; 111(2): 502-512, 2020 Feb.
Article in En | MEDLINE | ID: mdl-31710406
ABSTRACT
The present study was designed to evaluate the dynamic survival and recurrence of remnant gastric cancer (RGC) after radical resection and to provide a reference for the development of personalized follow-up strategies. A total of 298 patients were analyzed for their 3-year conditional overall survival (COS3), 3-year conditional disease-specific survival (CDSS3), corresponding recurrence and pattern changes, and associated risk factors. The 5-year overall survival (OS) and the 5-year disease-specific survival (DSS) of the entire cohort were 41.2% and 45.8%, respectively. The COS3 and CDDS3 of RGC patients who survived for 5 years were 84.0% and 89.8%, respectively. The conditional survival in patients with unfavorable prognostic characteristics showed greater growth over time than in those with favorable prognostic characteristics (eg, COS3, ≥T3 46.4%-83.0%, Δ36.6% vs ≤T2 82.4%-85.7%, Δ3.3%; P < 0.001). Most recurrences (93.5%) occurred in the first 3 years after surgery. The American Joint Committee on Cancer (AJCC) stage was the only factor that affected recurrence. Time-dependent Cox regression showed that for both OS and DSS, after 4 years of survival, the common prognostic factors that were initially judged lost their ability to predict survival (P > 0.05). Time-dependent logistic regression analysis showed that the AJCC stage independently affected recurrence within 2 years after surgery (P < 0.05). A postoperative follow-up model was developed for RGC patients. In conclusion, patients with RGC usually have a high likelihood of death or recurrence within 3 years after radical surgery. We developed a postoperative follow-up model for RGC patients of different stages, which may affect the design of future clinical trials.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gastric Stump / Neoplasm Recurrence, Local Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2020 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gastric Stump / Neoplasm Recurrence, Local Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2020 Type: Article Affiliation country: China